首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1140762

心臟手術設備全球市場-2022-2029

Global Cardiac Surgery Devices Market - 2022-2029

出版日期: 2022年10月20日 | 出版商:

DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

在預測期間（2022-2029 年），心臟手術設備市場預計將達到 8.4% 的複合年增長率。

心臟外科醫生對先天性心髒病、缺血性心髒病和瓣膜性心髒病等心臟並發症進行心臟手術。心臟設備製造商正在開發除現有設備之外的新設備，以提供治療心髒病的更多有用產品。

市場動態

主要驅動因素是心髒病發病率上升、人口老齡化和技術進步。

心血管疾病患病率的上升和老年人口的增加正在推動全球市場的增長。

預計心血管疾病發病率的增加將在預測期內提振市場。例如，根據英國心臟基金會的數據，2020 年將有大約 168,319 人死於心血管疾病。由於各種誘發因素，心血管疾病呈上升趨勢。老年人口不斷增加，可支配收入增加，生活方式改變，吸煙等等。據顯示有1億人。到2050年，預計老年人口將達到21億。此外，根據世界衛生組織 (WHO) 的數據，煙草消費每年導致超過 800 萬人死亡，其中約 700 萬人來自直接煙草使用，約 120 萬人為二手煙民。這被認為是接觸的結果吸煙。

嚴格的法規和心臟外科醫生的短缺正在阻礙全球心臟手術設備市場的增長。

然而，對醫療器械審批的嚴格規定、高昂的投資成本以及專業和熟練外科醫生的短缺預計將阻礙市場。執行心臟手術的熟練外科醫生短缺可能會限制市場。

行業分析。

《全球心臟手術器械市場報告》根據波特五力、創新、新產品發布、定價和流行病學分析等各種行業因素對市場進行了深入分析。

細分分析

預計在預測期內（2022-2029 年），微創手術領域的需求將很高。

預計微創手術領域將在預測期內（2022-2029 年）提振市場。微創心臟手術因其各種好處而越來越受歡迎，包括更少的手術創傷和更少的手術部位疼痛。此外，預計微創手術方法的最新進展將推動市場發展。例如，在機器人輔助心臟手術中，外科醫生在胸部一側做一個或多個小切口，並引導機械臂通過這些切口。機器人顯示出清晰的心臟圖像，外科醫生控制機械臂進行手術。

區域分析

預計北美將主導全球心臟手術設備市場。

北美在 2021 年主導了全球心臟手術設備市場。據估計，心血管疾病發病率的上升、技術的快速進步、人群意識的增強以及對微創手術的日益偏好將在預測期內（2022-2029 年）保持巨大的市場規模。預計心血管疾病發病率的增加將在預測期內推動市場。例如，根據 CDC 的數據，每 34 秒就有一名美國人死於心血管疾病，而 2020 年將有 697,000 名美國人死於心血管疾病。此外，每 40 秒就有一名美國人死於心血管疾病。冠心病佔心血管疾病死亡的大部分，其次是中風和心力衰竭。疾病預防控制中心估計，心髒病是美國的首要死因，造成五分之一的死亡。因此，心血管疾病的增加正在推動心臟手術設備市場。

競爭格局

在全球心臟手術設備市場運營的主要公司有 Medtronic、LivaNova plc、Terumo Corporation、Edwards Lifesciences Corporation、Boston Scientific Corporation、Abbott Laboratories、Getinge、Delacroix-Chevalier、Wexler Surgical、Rumex International 等。主要參與者正在採取各種策略，如產品發布、併購、合作夥伴和聯盟，這有助於全球心臟手術器械市場的增長。例如，2022 年 4 月 8 日，LivaNova 開始有針對性地商業推出體外循環患者監護儀 Essenz。同樣在 2022 年 7 月 21 日， Terumo India 與 Sensible Medical Innovations 建立了新的戰略商業分銷合作夥伴關係。

Medtronic, Plc.

是一個概述。

Medtronic PLC 是一家總部位於愛爾蘭的美國醫療器械製造商。美敦力成立於 1949 年，總部位於美國明尼蘇達州明尼阿波利斯。美敦力經營四項業務：微創治療組、糖尿病組、恢復性治療組和心血管組。

產品介紹。

Medtronic, Plc.的產品組合。心臟手術產品組合包括 Aquamantys 雙極封口機、單極封口機、PlasmaBlade 解剖裝置、Cardioblate 68000 手術消融系統發生器、Cardioblate 手術消融筆、Cardioblate(TM) BP2、Cardioblate LP 等。

全球心臟外科設備市場報告將提供對大約 40 多個市場數據表、45 多個數字和 200 頁（大約）的區域的訪問。

Market Overview

Cardiac Surgery Devices Market is estimated to reach at a CAGR of 8.4% during the forecast period (2022-2029).

Heart surgeons perform cardiac surgery due to the complications in the heart like congenital heart disease, ischemic heart disease, valvular heart disease, etc. Manufacturers of cardiac devices are developing novel instruments along with traditional devices to offer more usable products in treating cardiac diseases.

Market Dynamics

The major driving forces are the rising heart disease prevalence, the growing geriatric population, and technological advancements.

The increasing prevalence of cardiovascular disease and rising geriatric population are propelling the global market growth.

The increasing incidences of cardiovascular diseases are expected to boost the market over the forecast period. For instance, according to the British Heart Foundation, around 168,319 people died in 2020 from cardiovascular diseases. Cardiovascular diseases are rising due to various predisposing factors; examples of a few are the growing geriatric population, rising disposable income, changing lifestyles, smoking, and others; for instance, the world health organization data indicated that in 2020, there were around 1 billion people aged 60 and above. It is estimated that by 2050 the geriatric population will reach 2.1 billion. In addition to this, as per the World Health Organization, tobacco consumption has claimed over 8 million deaths every year globally, of which nearly 7 million are because of the direct use of tobacco, while close to 1.2 million are as a result of non-smokers exposed to secondhand smoke.

The stringent regulations and lack of cardiac surgeons hinder the global cardiac surgery devices market growth.

However, the stringent regulations for the approval of medical devices, high investment cost, and shortage of professional/skilled surgeons are expected to hamper the market. The shortage of skilled surgeons to perform cardiac surgeries is likely to restrain the market.

Industry analysis.

The global cardiac surgery devices market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, innovations, new product launches, pricing, epidemiological analysis, Etc.

Segment Analysis

The minimally invasive surgery segment is predicted to have a high demand during the forecast period (2022-2029).

The minimally invasive surgery segment is expected to boost the market over the forecast period (2022-2029). Minimally invasive cardiac surgery has surged in popularity because of the various benefits of this procedure, like reduced surgical trauma and decreased pain in the surgical area. Also, recent advancements in minimally invasive surgical approaches are expected to boost the market. For instance, Robotically assisted heart surgery is where the surgeon makes one or more small incisions in the side of the chest and guides robotic arms through these incisions. The robot shows clear images of the heart, and the surgeon controls the robotic arms to perform the procedure.

Geographical Analysis

North America is predicted to command the global cardiac surgery devices market.

North America dominated the global cardiac surgery devices market in 2021. It is estimated to hold a significant market size over the forecast period (2022-2029) owing to the increasing incidences of cardiovascular diseases, rapid technological advances, increasing awareness among the population, and the growing preference for minimally invasive procedures. The increasing incidences of cardiovascular diseases are expected to drive the market over the forecast period. For instance, according to the CDC, every 34 seconds, a U.S. American dies because of cardiovascular disease; in 2020, 697,000 American deaths were caused by cardiovascular disease. Also, among Americans, one person dies from cardiovascular disease every 40 seconds. Coronary heart disease accounts for most CVD deaths, followed by stroke and heart failure. CDC has estimated that heart disease is the leading cause of death in the U.S. and is responsible for 1 in every 5 deaths. Thus, the growing number of cardiovascular diseases drives the cardiac surgery devices market.

Competitive Landscape

The major players operating in the global cardiac surgery devices market are Medtronic, LivaNova plc, Terumo Corporation, Edwards Lifesciences Corporation, Boston Scientific Corporation, Abbott Laboratories, Getinge, Delacroix-Chevalier, Wexler Surgical, Rumex International. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, which are contributing to the growth of the cardiac surgery devices market globally. For instance, on Apr 08, 2022, LivaNova initiated a targeted commercial launch of the Essenz patient monitor for cardiopulmonary bypass procedures. Also, on July 21, 2022, Terumo India signed a new strategic commercial distribution partnership with Sensible Medical Innovations.

Medtronic, Plc.

Overview:

Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.

Product Portfolio:

The product portfolio of Medtronic, Plc. The product portfolio for Cardiac Surgery Devices contains Aquamantys bipolar sealers, Monopolar sealers, PlasmaBlade dissection devices, Cardioblate 68000 Surgical Ablation System Generator, Cardioblate Surgical Ablation Pens, Cardioblate™ BP2 , Cardioblate LP, Etc.

The global cardiac surgery devices market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

4.1. Market Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The Growing Prevalence of Cardio Vascular Diseases
  - 4.1.1.2. Growing Geriatric Population
  - 4.1.1.3. Market Strategies
- 4.1.2. Restraints
  - 4.1.2.1. Lack of Cardiac Surgeons
  - 4.1.2.2. Stringent Regulation
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of Covid-19 on the Market
- 6.1.1. Before COVID-19 Market Scenario
- 6.1.2. Present COVID-19 Market Scenario
- 6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer's Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
- 7.1.2. Market Attractiveness Index, By Product Type Segment
7.2. Beating Heart Surgery Systems
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  - 7.2.2.1. Stabilizers
  - 7.2.2.2. Positioners
7.3. Perfusion Disposables
- 7.3.1. Oxygenators
- 7.3.2. Centrifugal Pumps
- 7.3.3. Cardioplegia Delivery Systems
7.4. Cardiopulmonary Bypass Equipment
7.5. Catheters
- 7.5.1. Ablation Catheter
- 7.5.2. Drainage Catheter

8. By Procedure

8.1. Introduction
- 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Segment
- 8.1.2. Market Attractiveness Index, By Procedure Segment
8.2. Coronary Artery Bypass Grafting
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Minimally Invasive Surgery

9. By Type

9.1. Introduction
- 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
- 9.1.2. Market Attractiveness Index, By Type Segment
9.2. Interventional Cardiac Surgery
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Cardiac Rhythm Management
9.4. Traditional Cardiac Surgery
9.5. Others

10. By End User

10.1. Introduction
- 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
- 10.1.2. Market Attractiveness Index, By End User Segment
10.2. Hospitals
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Ambulatory Surgical Centers (ASCs)
10.4. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
- 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. The U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
- 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. The U.K.
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
- 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
- 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
- 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Product Benchmarking

13. Company Profiles

13.1. Medtronic Plc
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Key Highlights
- 13.1.4. Financial Overview
13.2. LivaNova plc
13.3. Terumo Corporation
13.4. Edwards Lifesciences Corporation
13.5. Boston Scientific Corporation
13.6. Abbott Laboratories
13.7. Getinge
13.8. Delacroix-Chevalier
13.9. Wexler Surgical
13.10. Rumex International

LIST NOT EXHAUSTIVE